Literature DB >> 25148596

The burden of influenza-associated critical illness hospitalizations.

Justin R Ortiz1, Kathleen M Neuzil, David K Shay, Tessa C Rue, Moni B Neradilek, Hong Zhou, Christopher W Seymour, Laura G Hooper, Po-Yung Cheng, Christopher H Goss, Colin R Cooke.   

Abstract

OBJECTIVE: Influenza is the most common vaccine-preventable disease in the United States; however, little is known about the burden of critical illness due to influenza virus infection. Our primary objective was to estimate the proportion of all critical illness hospitalizations that are attributable to seasonal influenza.
DESIGN: Retrospective cohort study.
SETTING: Arizona, California, and Washington from January 2003 to March 2009. PATIENTS: All adults hospitalized with critical illness, defined by International Classification of Diseases, 9th Edition, Clinical Modification diagnosis and procedure codes for acute respiratory failure, severe sepsis, or in-hospital death.
MEASUREMENTS AND MAIN RESULTS: We combined the complete hospitalization discharge databases for three U.S. states, regional influenza virus surveillance, and state census data. Using negative binomial regression models, we estimated the incidence rates of adult influenza-associated critical illness hospitalizations and compared them with all-cause event rates. We also compared modeled outcomes to International Classification of Diseases, 9th Edition, Clinical Modification-coded influenza hospitalizations to assess potential underrecognition of severe influenza disease. During the study period, we estimated that 26,760 influenza-associated critical illness hospitalizations (95% CI, 14,541, 47,464) occurred. The population-based incidence estimate for influenza-associated critical illness was 12.0 per 100,000 person-years (95% CI, 6.6, 21.6) or 1.3% of all critical illness hospitalizations (95% CI, 0.7%, 2.3%). During the influenza season, 3.4% of all critical illness hospitalizations (95% CI, 1.9%, 5.8%) were attributable to influenza. There were only 2,612 critical illness hospitalizations with International Classification of Diseases, 9th Edition, Clinical Modification-coded influenza diagnoses, suggesting influenza is either undiagnosed or undercoded in a substantial proportion of critical illness.
CONCLUSIONS: Extrapolating our data to the 2010 U.S. population, we estimate that about 28,000 adults are hospitalized for influenza-associated critical illness annually. Influenza in many of these critically ill patients may be undiagnosed. Critical care physicians should have a high index of suspicion for influenza in the ICU, particularly when influenza is known to be circulating in their communities.

Entities:  

Mesh:

Year:  2014        PMID: 25148596      PMCID: PMC4620028          DOI: 10.1097/CCM.0000000000000545

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  36 in total

1.  Benchmarking the incidence and mortality of severe sepsis in the United States.

Authors:  David F Gaieski; J Matthew Edwards; Michael J Kallan; Brendan G Carr
Journal:  Crit Care Med       Date:  2013-05       Impact factor: 7.598

2.  Estimates of deaths associated with seasonal influenza --- United States, 1976-2007.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-08-27       Impact factor: 17.586

3.  Prediction of critical illness during out-of-hospital emergency care.

Authors:  Christopher W Seymour; Jeremy M Kahn; Colin R Cooke; Timothy R Watkins; Susan R Heckbert; Thomas D Rea
Journal:  JAMA       Date:  2010-08-18       Impact factor: 56.272

4.  Identifying patients with severe sepsis using administrative claims: patient-level validation of the angus implementation of the international consensus conference definition of severe sepsis.

Authors:  Theodore J Iwashyna; Andrew Odden; Jeffrey Rohde; Catherine Bonham; Latoya Kuhn; Preeti Malani; Lena Chen; Scott Flanders
Journal:  Med Care       Date:  2014-06       Impact factor: 2.983

5.  High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections.

Authors:  N Lee; G C Y Lui; K T Wong; T C M Li; E C M Tse; J Y C Chan; J Yu; S S M Wong; K W Choi; R Y K Wong; K L K Ngai; D S C Hui; P K S Chan
Journal:  Clin Infect Dis       Date:  2013-07-21       Impact factor: 9.079

6.  Influenza-associated hospitalizations in the United States.

Authors:  William W Thompson; David K Shay; Eric Weintraub; Lynnette Brammer; Carolyn B Bridges; Nancy J Cox; Keiji Fukuda
Journal:  JAMA       Date:  2004-09-15       Impact factor: 56.272

7.  Estimating the undetected burden of influenza hospitalizations in children.

Authors:  C G Grijalva; G A Weinberg; N M Bennett; M A Staat; A S Craig; W D Dupont; M K Iwane; A S Postema; W Schaffner; K M Edwards; M R Griffin
Journal:  Epidemiol Infect       Date:  2006-12-07       Impact factor: 2.451

8.  Monitoring influenza activity in the United States: a comparison of traditional surveillance systems with Google Flu Trends.

Authors:  Justin R Ortiz; Hong Zhou; David K Shay; Kathleen M Neuzil; Ashley L Fowlkes; Christopher H Goss
Journal:  PLoS One       Date:  2011-04-27       Impact factor: 3.240

9.  Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009.

Authors:  Carrie Reed; Frederick J Angulo; David L Swerdlow; Marc Lipsitch; Martin I Meltzer; Daniel Jernigan; Lyn Finelli
Journal:  Emerg Infect Dis       Date:  2009-12       Impact factor: 6.883

10.  Estimating influenza hospitalizations among children.

Authors:  Carlos G Grijalva; Allen S Craig; William D Dupont; Carolyn B Bridges; Stephanie J Schrag; Marika K Iwane; William Schaffner; Kathryn M Edwards; Marie R Griffin
Journal:  Emerg Infect Dis       Date:  2006-01       Impact factor: 6.883

View more
  32 in total

1.  Duration of Stay of Patients with Community-Acquired Pneumonia in Influenza Season.

Authors:  Emel Tellioğlu; Günseli Balcı; Aydan Mertoğlu
Journal:  Turk Thorac J       Date:  2018-06-12

Review 2.  Antibody immunoprophylaxis and immunotherapy for influenza virus infection: Utilization of monoclonal or polyclonal antibodies?

Authors:  Cassandra M Berry
Journal:  Hum Vaccin Immunother       Date:  2017-11-07       Impact factor: 3.452

3.  Neighborhood Influences on Seasonal Influenza Vaccination among Older African Americans in Atlanta, Georgia.

Authors:  N Niyibizi; J Schamel; P M Frew
Journal:  J Immunol Tech Infect Dis       Date:  2016-03-23

4.  Influenza A virus-induced host caspase and viral PA-X antagonize the antiviral host factor, histone deacetylase 4.

Authors:  Henry D Galvin; Matloob Husain
Journal:  J Biol Chem       Date:  2019-11-22       Impact factor: 5.157

Review 5.  Vaccination of immune compromised children-an overview for physicians.

Authors:  Laure F Pittet; Klara M Posfay-Barbe
Journal:  Eur J Pediatr       Date:  2021-03-05       Impact factor: 3.183

6.  Corticosteroids as adjunctive therapy in the treatment of influenza.

Authors:  Louise Lansbury; Chamira Rodrigo; Jo Leonardi-Bee; Jonathan Nguyen-Van-Tam; Wei Shen Lim
Journal:  Cochrane Database Syst Rev       Date:  2019-02-24

7.  Improving Accuracy of Influenza-Associated Hospitalization Rate Estimates.

Authors:  Alexander J Millman; Carrie Reed; Pam Daily Kirley; Deborah Aragon; James Meek; Monica M Farley; Patricia Ryan; Jim Collins; Ruth Lynfield; Joan Baumbach; Shelley Zansky; Nancy M Bennett; Brian Fowler; Ann Thomas; Mary L Lindegren; Annette Atkinson; Lyn Finelli; Sandra S Chaves
Journal:  Emerg Infect Dis       Date:  2015-09       Impact factor: 6.883

8.  Relationship Between Upper Respiratory Tract Influenza Test Result and Clinical Outcomes Among Critically Ill Influenza Patients.

Authors:  Krishna P Reddy; Ednan K Bajwa; Robert A Parker; Andrew B Onderdonk; Rochelle P Walensky
Journal:  Open Forum Infect Dis       Date:  2016-03-08       Impact factor: 3.835

9.  Impact of Influenza on Outpatient Visits, Hospitalizations, and Deaths by Using a Time Series Poisson Generalized Additive Model.

Authors:  Ru-ning Guo; Hui-zhen Zheng; Chun-quan Ou; Li-qun Huang; Yong Zhou; Xin Zhang; Can-kun Liang; Jin-yan Lin; Hao-jie Zhong; Tie Song; Hui-ming Luo
Journal:  PLoS One       Date:  2016-02-19       Impact factor: 3.240

10.  Preserved antiviral adaptive immunity following polyclonal antibody immunotherapy for severe murine influenza infection.

Authors:  Natalie E Stevens; Antoinette Hatjopolous; Cara K Fraser; Mohammed Alsharifi; Kerrilyn R Diener; John D Hayball
Journal:  Sci Rep       Date:  2016-07-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.